Literature DB >> 487523

Evoked release of endogenous norepinephrine in the canine saphenous vein. Inhibition by acetylcholine.

P M Vanhoutte, E P Coen, W J De Ridder, T J Verbeuren.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 487523     DOI: 10.1161/01.res.45.5.608

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  7 in total

1.  Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.

Authors:  M A Creager; J P Cooke; M E Mendelsohn; S J Gallagher; S M Coleman; J Loscalzo; V J Dzau
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

2.  Deamination of released 3H-noradrenaline in the canine saphenous vein.

Authors:  T J Verbeuren; P M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

3.  Roles of extrajunctional receptors in the response of guinea-pig mesenteric and rat tail arteries to adrenergic nerves.

Authors:  T Itoh; K Kitamura; H Kuriyama
Journal:  J Physiol       Date:  1983-12       Impact factor: 5.182

4.  Comparison of the responsiveness of isolated arteries and veins taken from the same dogs 17 days apart.

Authors:  T J Verbeuren; E Coen; W De Ridder; P M Vanhoutte
Journal:  Experientia       Date:  1981-06

5.  Tissue accumulation and release of newly synthesized 3H-dopamine and 3H-noradrenaline in canine saphenous veins incubated with 3H-(--)-tyrosine.

Authors:  P J Boels; T J Verbeuren; P M Vanhoutte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

6.  The effect of profound cooling on adrenergic neurotransmission in canine cutaneous veins.

Authors:  N J Rusch; J T Shepherd; P M Vanhoutte
Journal:  J Physiol       Date:  1981-02       Impact factor: 5.182

7.  Muscarinic Receptor Type-3 in Hypertension and Cholinergic-Adrenergic Crosstalk: Genetic Insights and Potential for New Antihypertensive Targets.

Authors:  Rhéure Alves-Lopes; Karla B Neves; Rhian M Touyz
Journal:  Can J Cardiol       Date:  2019-02-13       Impact factor: 5.223

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.